Pfizer temporarily suspends Premarin vaginal cream in India due to supply constraints, while exploring options to restore availability.

Pfizer has paused Premarin vaginal cream supply in India due to supply challenges, limiting menopause treatment options and raising concerns over estrogen therapy access.

Pfizer temporarily suspends Premarin vaginal cream in India due to supply constraints, while exploring options to restore availability.